Meldream Pr

Melatonin, the active ingredient in Meldream Pr, is a melatonin receptor agonist presented as an oral tablet for oral use. It treats insomnia, jet lag and sleep onset difficulties in adults. GNH USA supplies Meldream Pr as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Melatonin acts on the melatonin receptor pathway to regulate circadian rhythm and is used for sleep‑related disorders.

Insomnia: helps reduce the time needed to fall asleep. Jet lag: assists in adjusting the sleep‑wake cycle after rapid time‑zone travel. Sleep onset difficulties: promotes earlier sleep initiation in adults.

Melatonin is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects: - Drowsiness - Headache - Dizziness - Nausea - Vivid dreams

Serious or Rare Side Effects: - Allergic reactions such as rash or itching - Mood changes including depression or irritability - Hormonal effects such as altered menstrual cycles

Before using Meldream Pr, consider the following safety measures.

Assess renal function: adjust use in severe impairment. Avoid use with shift work: efficacy may be reduced. Do not combine with other sedatives without medical advice. Monitor for daytime sleepiness: advise caution when driving. Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Melatonin can interact with several medicines; review the following categories.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): may increase bleeding risk. - Immunosuppressants (e.g., cyclosporine): may alter melatonin levels. - Central nervous system depressants (e.g., benzodiazepines): additive sedation.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may reduce contraceptive efficacy. - Antidepressants (e.g., SSRIs): potential for serotonin syndrome. - Caffeine: may diminish melatonin’s sleep‑promoting effect.